Nanologica Investor Relations Material
Latest events
Q1 2025
16 Apr, 2025
Q4 2024
14 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Nanologica
Access all reports
Nanologica AB, a nanotechnology company, develops nanoporous silica for applications in the life science industry. Its technology combines a biologically active component with nano-sized pores to improve the delivery of drugs and vaccines to the target via controlled release mechanisms. The company’s products include Nano-pillars and Nano-spheres that are used in various applications such as biological treatments, diagnostics, or therapeutic medicines, as well as drug formulations in pharmaceuticals and other industries. Nanologica AB was founded in 2004 and is based in Södertälje, Sweden.
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
NICA
Country
🇸🇪 Sweden